Related Experiment Video
Updated: Jul 2, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Approach to the patient with prediabetes
Vanita R Aroda1, Robert Ratner
1Med Star Clinical Research Center, 650 Pennsylvania Avenue SE, Washington, DC 20003, USA.
The Journal of Clinical Endocrinology and Metabolism
|September 6, 2008
Summary
Prediabetes, a precursor to type 2 diabetes, can be effectively delayed through lifestyle changes and medication. Early intervention is crucial for managing impaired glucose levels and preventing serious health complications.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Public Health
Background:
- Prediabetes, characterized by impaired fasting glucose and/or impaired glucose tolerance, is a critical precursor to type 2 diabetes.
- It signifies an intermediate stage between normal glucose metabolism and overt hyperglycemia, increasing risks for microvascular and macrovascular complications.
Purpose of the Study:
- To review current understanding and management strategies for prediabetes.
- To interpret available data to guide clinical decision-making regarding identification and treatment.
Main Methods:
- Review of large, randomized prospective studies.
- Analysis of interventions including lifestyle modifications and pharmacotherapy.
- Interpretation of data on controversial management aspects.
Main Results:
- Strong evidence supports interventions to delay the progression from prediabetes to type 2 diabetes.
- Lifestyle interventions and pharmacotherapy have demonstrated success in delaying diabetes onset.
- Controversies remain regarding the role and escalation of pharmacotherapy.
Conclusions:
- Intervention is strongly supported to delay diabetes progression in prediabetes.
- Management strategies, including pharmacotherapy, require careful consideration and interpretation of evidence.
- Further clarity is needed on optimal treatment escalation pathways.
Related Concept Videos
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...